TRIMTECH Therapeutics
Cambridge
About TRIMTECH Therapeutics
TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $31.0M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: trimtechtherapeutics.com
- Phone: +44 (0)1223 767800
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/trimtech-therapeutics-62987 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.